Journal for ImmunoTherapy of Cancer (Nov 2020)
565 A novel long-acting interleukin-7 agonist, NT-I7, increases cytotoxic CD8+ T cells and enhances survival in mouse glioma models
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2020)